287 related articles for article (PubMed ID: 17211832)
1. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry.
Pan S; Zhu D; Quinn JF; Peskind ER; Montine TJ; Lin B; Goodlett DR; Taylor G; Eng J; Zhang J
Proteomics; 2007 Feb; 7(3):469-73. PubMed ID: 17211832
[TBL] [Abstract][Full Text] [Related]
2. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of the cerebrospinal fluid peptidome and proteome.
Zougman A; Pilch B; Podtelejnikov A; Kiehntopf M; Schnabel C; Kumar C; Mann M
J Proteome Res; 2008 Jan; 7(1):386-99. PubMed ID: 18052119
[TBL] [Abstract][Full Text] [Related]
4. Proteomics analysis of human cerebrospinal fluid.
Yuan X; Desiderio DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
6. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid.
Yuan X; Desiderio DM
Proteomics; 2005 Feb; 5(2):541-50. PubMed ID: 15627968
[TBL] [Abstract][Full Text] [Related]
7. Relative quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags.
Dayon L; Hainard A; Licker V; Turck N; Kuhn K; Hochstrasser DF; Burkhard PR; Sanchez JC
Anal Chem; 2008 Apr; 80(8):2921-31. PubMed ID: 18312001
[TBL] [Abstract][Full Text] [Related]
8. Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach.
Pan S; Wang Y; Quinn JF; Peskind ER; Waichunas D; Wimberger JT; Jin J; Li JG; Zhu D; Pan C; Zhang J
J Proteome Res; 2006 Oct; 5(10):2769-79. PubMed ID: 17022648
[TBL] [Abstract][Full Text] [Related]
9. Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid.
Burgess JA; Lescuyer P; Hainard A; Burkhard PR; Turck N; Michel P; Rossier JS; Reymond F; Hochstrasser DF; Sanchez JC
J Proteome Res; 2006 Jul; 5(7):1674-81. PubMed ID: 16823975
[TBL] [Abstract][Full Text] [Related]
10. Identification of glycoproteins in human cerebrospinal fluid.
Hwang HJ; Quinn T; Zhang J
Methods Mol Biol; 2009; 566():263-76. PubMed ID: 20058177
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive proteome map of bovine cerebrospinal fluid.
Brenn A; Karger A; Skiba M; Ziegler U; Groschup MH
Proteomics; 2009 Nov; 9(22):5199-205. PubMed ID: 19921684
[TBL] [Abstract][Full Text] [Related]
12. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
13. The proteomic toolbox for studying cerebrospinal fluid.
van Gool AJ; Hendrickson RC
Expert Rev Proteomics; 2012 Apr; 9(2):165-79. PubMed ID: 22462788
[TBL] [Abstract][Full Text] [Related]
14. In-depth proteomic profiling of the normal human kidney glomerulus using two-dimensional protein prefractionation in combination with liquid chromatography-tandem mass spectrometry.
Miyamoto M; Yoshida Y; Taguchi I; Nagasaka Y; Tasaki M; Zhang Y; Xu B; Nameta M; Sezaki H; Cuellar LM; Osawa T; Morishita H; Sekiyama S; Yaoita E; Kimura K; Yamamoto T
J Proteome Res; 2007 Sep; 6(9):3680-90. PubMed ID: 17711322
[TBL] [Abstract][Full Text] [Related]
15. Proteomics of cerebrospinal fluid: methods for sample processing.
Hale JE; Gelfanova V; You JS; Knierman MD; Dean RA
Methods Mol Biol; 2008; 425():53-66. PubMed ID: 18369886
[TBL] [Abstract][Full Text] [Related]
16. Different immunoaffinity fractionation strategies to characterize the human plasma proteome.
Gong Y; Li X; Yang B; Ying W; Li D; Zhang Y; Dai S; Cai Y; Wang J; He F; Qian X
J Proteome Res; 2006 Jun; 5(6):1379-87. PubMed ID: 16739989
[TBL] [Abstract][Full Text] [Related]
17. Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysis.
Shores KS; Knapp DR
J Proteome Res; 2007 Sep; 6(9):3739-51. PubMed ID: 17696521
[TBL] [Abstract][Full Text] [Related]
18. The human cerebrospinal fluid metabolome.
Wishart DS; Lewis MJ; Morrissey JA; Flegel MD; Jeroncic K; Xiong Y; Cheng D; Eisner R; Gautam B; Tzur D; Sawhney S; Bamforth F; Greiner R; Li L
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(2):164-73. PubMed ID: 18502700
[TBL] [Abstract][Full Text] [Related]
19. CSF proteome: a protein repository for potential biomarker identification.
Romeo MJ; Espina V; Lowenthal M; Espina BH; Petricoin EF; Liotta LA
Expert Rev Proteomics; 2005 Jan; 2(1):57-70. PubMed ID: 15966853
[TBL] [Abstract][Full Text] [Related]
20. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
Yin GN; Lee HW; Cho JY; Suk K
Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
